FDA Clearance Tracker · K162827
VIDAS B.R.A.H.M.S. PCT (PCT)
Last checked: Nov 20, 2026Latest source record: Feb 23, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Feb 23, 2017
Substantially Equivalent
Time to decision
139 days
Received Oct 7, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K162827
- Device name
- VIDAS B.R.A.H.M.S. PCT (PCT)
- Applicant
- bioMerieux, Inc.
- Applicant location
- Hazelwood, MO
- Received
- Oct 7, 2016
- Decided
- Feb 23, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Procalcitonin Assay (PRI)
- Device class
- Class II
- Regulation
- 21 CFR 866.3215
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PRI (Procalcitonin Assay).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K162827
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for bioMerieux, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262807 · Decided Nov 4, 2026 · 89 days after receipt
Device type: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (LON) · Laboratory Medicine & Pathology
K260283 · Decided Oct 1, 2026 · 245 days after receipt
Device type: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (LON) · Laboratory Medicine & Pathology
K260160 · Decided Jul 8, 2026 · 169 days after receipt
Device type: Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples (SAN) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.